BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 32154766)

  • 21. Anthrax toxin receptor 1/tumor endothelial marker 8 promotes gastric cancer progression through activation of the PI3K/AKT/mTOR signaling pathway.
    Cai C; Dang W; Liu S; Huang L; Li Y; Li G; Yan S; Jiang C; Song X; Hu Y; Gu J
    Cancer Sci; 2020 Apr; 111(4):1132-1145. PubMed ID: 31977138
    [TBL] [Abstract][Full Text] [Related]  

  • 22. AFAP1L1 promotes gastric cancer progression by interacting with VAV2 to facilitate CDC42-mediated activation of ITGA5 signaling pathway.
    Sun B; Ding B; Chen Y; Peng C; Chen X
    J Transl Med; 2023 Jan; 21(1):18. PubMed ID: 36631800
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of ERM-family proteins via RhoA-ROCK signaling increases intestinal P-gp expression and leads to attenuation of oral morphine analgesia.
    Kobori T; Harada S; Nakamoto K; Tokuyama S
    J Pharm Sci; 2013 Mar; 102(3):1095-105. PubMed ID: 23303573
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Signaling pathways that control rho kinase activity maintain the embryonic epicardial progenitor state.
    Artamonov MV; Jin L; Franke AS; Momotani K; Ho R; Dong XR; Majesky MW; Somlyo AV
    J Biol Chem; 2015 Apr; 290(16):10353-67. PubMed ID: 25733666
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Crk associates with ERM proteins and promotes cell motility toward hyaluronic acid.
    Tsuda M; Makino Y; Iwahara T; Nishihara H; Sawa H; Nagashima K; Hanafusa H; Tanaka S
    J Biol Chem; 2004 Nov; 279(45):46843-50. PubMed ID: 15326184
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ARHGEF3 controls HDACi-induced differentiation via RhoA-dependent pathways in acute myeloid leukemias.
    D'Amato L; Dell'Aversana C; Conte M; Ciotta A; Scisciola L; Carissimo A; Nebbioso A; Altucci L
    Epigenetics; 2015; 10(1):6-18. PubMed ID: 25494542
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miR-218 Inhibits Proliferation, Migration, and EMT of Gastric Cancer Cells by Targeting WASF3.
    Wang G; Fu Y; Liu G; Ye Y; Zhang X
    Oncol Res; 2017 Mar; 25(3):355-364. PubMed ID: 27642088
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long non-coding RNA CASC15 regulates gastric cancer cell proliferation, migration and epithelial mesenchymal transition by targeting CDKN1A and ZEB1.
    Wu Q; Xiang S; Ma J; Hui P; Wang T; Meng W; Shi M; Wang Y
    Mol Oncol; 2018 Jun; 12(6):799-813. PubMed ID: 29489064
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Supervillin promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma in hypoxia via activation of the RhoA/ROCK-ERK/p38 pathway.
    Chen X; Zhang S; Wang Z; Wang F; Cao X; Wu Q; Zhao C; Ma H; Ye F; Wang H; Fang Z
    J Exp Clin Cancer Res; 2018 Jun; 37(1):128. PubMed ID: 29954442
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Podoplanin binds ERM proteins to activate RhoA and promote epithelial-mesenchymal transition.
    Martín-Villar E; Megías D; Castel S; Yurrita MM; Vilaró S; Quintanilla M
    J Cell Sci; 2006 Nov; 119(Pt 21):4541-53. PubMed ID: 17046996
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rho-ROCK-dependent ezrin-radixin-moesin phosphorylation regulates Fas-mediated apoptosis in Jurkat cells.
    Hébert M; Potin S; Sebbagh M; Bertoglio J; Bréard J; Hamelin J
    J Immunol; 2008 Nov; 181(9):5963-73. PubMed ID: 18941185
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of "regulation of RhoA activity panel" as a prognostic and predictive biomarker for gastric cancer.
    Huang W; Zhao S; Zhang C; Li Z; Ge S; Lian B; Feng H; Wang K; Xu R; Ji J; Gao J; Shi W; Shen L
    Aging (Albany NY); 2020 Dec; 13(1):714-734. PubMed ID: 33288739
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of the RhoA/ROCK/AKT/β-catenin pathway by arginine-specific ADP-ribosytransferases 1 promotes migration and epithelial-mesenchymal transition in colon carcinoma.
    Song GL; Jin CC; Zhao W; Tang Y; Wang YL; Li M; Xiao M; Li X; Li QS; Lin X; Chen WW; Kuang J
    Int J Oncol; 2016 Aug; 49(2):646-56. PubMed ID: 27277835
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metastasis suppressor protein 1 regulated by PTEN suppresses invasion, migration, and EMT of gastric carcinoma by inactivating PI3K/AKT signaling.
    Wang H; Zhao Y; Cao L; Zhang J; Wang Y; Xu M
    J Cell Biochem; 2019 Mar; 120(3):3447-3454. PubMed ID: 30246429
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interplay between RAGE, CD44, and focal adhesion molecules in epithelial-mesenchymal transition of alveolar epithelial cells.
    Buckley ST; Medina C; Kasper M; Ehrhardt C
    Am J Physiol Lung Cell Mol Physiol; 2011 Apr; 300(4):L548-59. PubMed ID: 21278261
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HMGA1 accelerates the malignant progression of gastric cancer through stimulating EMT.
    Jin GH; Shi Y; Tian Y; Cao TT; Mao Y; Tang TY
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3642-3647. PubMed ID: 32329839
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The calcium pump PMCA4 prevents epithelial-mesenchymal transition by inhibiting NFATc1-ZEB1 pathway in gastric cancer.
    Wang T; Li N; Jin L; Qi X; Zhang C; Hua D
    Biochim Biophys Acta Mol Cell Res; 2020 Dec; 1867(12):118833. PubMed ID: 32860837
    [TBL] [Abstract][Full Text] [Related]  

  • 38. p190A inactivating mutations cause aberrant RhoA activation and promote malignant transformation via the Hippo-YAP pathway in endometrial cancer.
    Wen X; Wan J; He Q; Wang M; Li S; Jiang M; Qian Z; Liu B; Lu W; Wang K; Gao K; Wan X
    Signal Transduct Target Ther; 2020 May; 5(1):81. PubMed ID: 32457342
    [TBL] [Abstract][Full Text] [Related]  

  • 39. miR-218 inhibits gastric tumorigenesis through regulating Bmi-1/Akt signaling pathway.
    Wu Y; Tian S; Chen Y; Ji M; Qu Y; Hou P
    Pathol Res Pract; 2019 Feb; 215(2):243-250. PubMed ID: 30420101
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ZNF143 enhances metastasis of gastric cancer by promoting the process of EMT through PI3K/AKT signaling pathway.
    Wei S; Wang L; Zhang L; Li B; Li Z; Zhang Q; Wang J; Chen L; Sun G; Li Q; Xu H; Zhang D; Xu Z
    Tumour Biol; 2016 Sep; 37(9):12813-12821. PubMed ID: 27449034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.